Archives of Clinical Infectious Diseases

Published by: Kowsar

Epidemiology and Treatment Outcome of Mucormycosis in Khuzestan, Southwest of Iran

Roohangiz Nashibi 1 , 2 , Sara Afzalzadeh 1 , 2 , Mohammad Javad Mohammadi 3 , 4 , 5 , Ahmad Reza Yari 6 and Farid Yousefi 1 , 2 , *
Authors Information
1 Health Research Institute, Infectious and Tropical Diseases Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2 Department of Infectious and Tropical Diseases, Razi Hospital, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
3 Abadan School of Medical Sciences, Abadan, Iran
4 Razi Teaching Hospital, Clinical Research Development Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5 Student Research Committee, Department of Environmental Health Engineering, School of Public Health and Environmental Technologies Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
6 Research Center for Environmental Pollutants, Qom University of Medical Sciences, Qom, Iran
Article information
  • Archives of Clinical Infectious Diseases: January 2017, 12 (1); e37221
  • Published Online: October 9, 2016
  • Article Type: Research Article
  • Received: February 18, 2016
  • Revised: September 3, 2016
  • Accepted: September 28, 2016
  • DOI: 10.5812/archcid.37221

To Cite: Nashibi R, Afzalzadeh S, Mohammadi M J, Yari A R, Yousefi F. Epidemiology and Treatment Outcome of Mucormycosis in Khuzestan, Southwest of Iran, Arch Clin Infect Dis. 2017 ; 12(1):e37221. doi: 10.5812/archcid.37221.

Abstract
Copyright © 2016, Infectious Diseases and Tropical Medicine Research Center. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Kontoyiannis DP, Lewis RE. Agents of mucormycosis and entomophthoramycosis. 2010;
  • 2. Chowdhary A, Agarwal K, Meis JF. Filamentous Fungi in Respiratory Infections. What Lies Beyond Aspergillosis and Mucormycosis? PLoS Pathog. 2016; 12(4): 1005491[DOI][PubMed]
  • 3. Sharma D, Dahal K, Pathak B, Dahal U. Case of early-disseminated Rhizopus microsporus var. microsporus mucormycosis in a renal transplant patient. Int Med Case Rep J. 2016; 9: 139-43[DOI][PubMed]
  • 4. Vaezi A, Moazeni M, Rahimi M, Hoog S, Badali H. Mucormycosis in Iran: a systematic review. Mycoses. 2016;
  • 5. Chakrabarti A, Singh R. Mucormycosis in India: unique features. Mycoses. 2014; 57 Suppl 3: 85-90[DOI][PubMed]
  • 6. Epstein JB, Kupferman SB, Zabner R, Rejali A, Hopp ML, Lill M, et al. Early diagnosis and successful management of oral mucormycosis in a hematopoietic stem cell transplant recipient: case report and literature review. Supportive Care Cancer. 2016; : 1-4
  • 7. Faraji E, Nakhjavani M, Mashrabi O, Maleki S, Maleki R. A brief review of mucormycosis: Report of five cases. BJMMR. 2016; 11(9): 1-5
  • 8. Yari AR, Goudarzi G, Geravandi S, Dobaradaran S, Yousefi F, Idani E, et al. Study of ground-level ozone and its health risk assessment in residents in Ahvaz city, Iran during 2013. Toxin Reviews. 2016; 35(3-4): 201-6
  • 9. Park JH, Park SH, Kang EG, Kyung G, An HD, An S. Cutaneous mucormycosis in a patient with diabetes mellitus. Ewha Med J. 2016; 39(1): 10-3
  • 10. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis. 2012; 54 Suppl 1-34[DOI][PubMed]
  • 11. Miceli MH, Kauffman CA. Treatment options for mucormycosis. Cur Treat Options Infect Dis. 2015; 7(3): 142-54
  • 12. Mendez HH, Hidalgo A. Endodontic patient with rhinocerebral mucormycosis. Revista Odontologica Mexicana. 2015; 19(2): 120-5
  • 13. Lim MY, Alker AP, Califano S, Trembath DG, Alby K, Gilligan PH, et al. Concurrent Disseminated Nocardiosis and GI Mucormycosis in a Stem-Cell Transplantation Recipient. J Clin Oncol. 2016; 34(10): 84-6[DOI][PubMed]
  • 14. Hong HL, Lee YM, Kim T, Lee JY, Chung YS, Kim MN, et al. Risk factors for mortality in patients with invasive mucormycosis. Infect Chemother. 2013; 45(3): 292-8[DOI][PubMed]
  • 15. Neblett Fanfair R, Benedict K, Bos J, Bennett SD, Lo YC, Adebanjo T, et al. Necrotizing cutaneous mucormycosis after a tornado in Joplin, Missouri, in 2011. N Engl J Med. 2012; 367(23): 2214-25[DOI][PubMed]
  • 16. Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41(5): 634-53[DOI][PubMed]
  • 17. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis. 2012; 54 Suppl 1-22[DOI][PubMed]
  • 18. Goudarzi G, Geravandi S, Foruozandeh H, Babaei AA, Alavi N, Niri MV, et al. Cardiovascular and respiratory mortality attributed to ground-level ozone in Ahvaz, Iran. Environ Monit Assess. 2015; 187(8): 487[DOI][PubMed]
  • 19. Salmanzadeh S, Yousefi F, Ahmadi F, Geravandi S, Moien M, Mohammadi M, et al. Evaluation of Nosocomial Infections in a Teaching Hospital. Avicenna J Clin Microbiol Infect. 2015; 2(3)
  • 20. Mohinisingh D. Mucormycosis an Emerging Fungal Infection. Indian J app Res. 2015; 5(8): 661-4
  • 21. Sachdeva K. Rhino-oculo Cerebral Mucormycosis with Multiple Cranial Nerve Palsy in Diabetic Patient: Review of Six Cases. Indian J Otolaryngol Head Neck Surg. 2013; 65(4): 375-9[DOI][PubMed]
  • 22. Saegeman V, Maertens J, Ectors N, Meersseman W, Lagrou K. Epidemiology of mucormycosis: review of 18 cases in a tertiary care hospital. Med Mycol. 2010; 48(2): 245-54[DOI][PubMed]
  • 23. Khor B, Lee M, Leu H, Liu J. Rhinocerebral mucormycosis in Taiwan. J microbiol immunol infect. 2003; 36(4): 266-9
  • 24. Barati M, Talebi-Taher M, Nojomi M, Kerami F. Ten-year experience of rhinocerebral zygomycosis in a teaching hospital in Tehran. Arch Clin Infect Dis. 2010; 5(3): 117-20
  • 25. Bitar D, Van Cauteren D, Lanternier F, Dannaoui E, Che D, Dromer F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997-2006. Emerg Infect Dis. 2009; 15(9): 1395-401[DOI][PubMed]
  • 26. Sarvestani AS, Pishdad G, Bolandparvaz S. Predisposing factors for mucormycosis in patients with diabetes mellitus; an experience of 21 years in southern iran. Bulletin Emerg Traum. 2013; 1(4): 164
  • 27. Komur S, İnal A, Kurtaran B, Ulu A, Uguz A, Aksu H, et al. Mucormycosis: a 10-year experience at a tertiary care center in Turkey. Turkish J Med Sci. 2016; 46(1): 58-62
  • 28. Pagano L, Ricci P, Tonso A, Nosari A, Cudillo L, Montillo M, et al. Mucormycosis in patients with haematological malignancies: a retrospective clinical study of 37 cases. GIMEMA Infection Program (Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto). Br J Haematol. 1997; 99(2): 331-6[PubMed]
  • 29. Bartzokas CA. Relationship between the metereological conditions and the air-borne fungal flora of the Athens metropolitan area. Mycopathologia. 1975; 57(1): 35-8[PubMed]
  • 30. El-Herte RI, Baban TA, Kanj SS. Mucormycosis: a review on environmental fungal spores and seasonal variation of human disease. Adv Infect Dis. 2012; 2(3): 76
  • 31. Chakrabarti A, Das A, Mandal J, Shivaprakash MR, George VK, Tarai B, et al. The rising trend of invasive zygomycosis in patients with uncontrolled diabetes mellitus. Med Mycol. 2006; 44(4): 335-42[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments